Product mentioned on podcasts
COMP360
by Compass Pathways
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links. As an Amazon Associate, SignalCast earns from qualifying purchases.
Who mentioned it
- Kabir NathAuthor
“Compass Pathways CEO Kabir Nath discusses COMP360, a psilocybin-based treatment for treatment-resistant depression, as the company prepares three phase three trial readouts over the next fifteen to eighteen months.”
Mentioned on: Pathfinders in Biopharma